Activation function 2 (AF2) domain of estrogen receptor-α regulates mechanotransduction during bone fracture healing in estrogen-competent mice

被引:2
|
作者
Steppe, Lena [1 ]
Krueger, Benjamin [1 ]
Tschaffon-Mueller, Miriam Eva Angelica [1 ]
Ramge, Jan-Moritz [1 ]
Schoppa, Astrid [1 ]
Ignatius, Anita [1 ]
Haffner-Luntzer, Melanie [1 ]
机构
[1] Univ Med Ctr Ulm, Inst Orthoped Res & Biomech, Helmholtzstr 14, D-89081 Ulm, Germany
关键词
Estrogen receptor signaling; AF-2; Whole-body vibration; Fracture healing; LMHFV; Mechanotransduction; HIGH-FREQUENCY VIBRATION; WHOLE-BODY VIBRATION; LOW-MAGNITUDE; GENE-EXPRESSION; CYTOSKELETAL; YAP/TAZ; STRAIN;
D O I
10.1016/j.bone.2023.116781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
External mechanostimulation applied by whole-body low-magnitude high-frequency vibration (LMHFV) was demonstrated to cause no or negative effects on fracture healing in estrogen-competent rodents, while in ovariectomized (OVX), estrogen-deficient rodents bone formation after fracture was improved. Using mice with an osteoblast-specific deletion of the estrogen receptor alpha (ER alpha), we demonstrated that ER alpha signaling in osteoblasts is required for both the anabolic and catabolic effects of LMHFV during bone fracture healing in OVX and non-OVX mice, respectively. Because the vibration effects mediated by ER alpha were strictly dependent on the estrogen status, we hypothesized different roles of ligand-dependent and -independent ER alpha signaling. To investigate this assumption in the present study, we used mice with a deletion of the C-terminal activation function (AF) domain-2 of the ER alpha receptor, which mediated ligand-dependent ER alpha signaling (ER alpha AF-20). OVX and non-OVX ER alpha AF-20 animals were subjected to femur osteotomy followed by vibration treatment. We revealed that estrogen-competent mice lacking the AF-2 domain were protected from LMHFV-induced impaired bone regeneration, while the anabolic effects of vibration in OVX mice were not affected by the AF-2 knockout. RNA sequencing further showed that genes involved in Hippo/Yap1-Taz and Wnt signaling were significantly downregulated upon LMHFV in the presence of estrogen in vitro. In conclusion, we demonstrated that the AF-2 domain is crucial for the negative effects of vibration during bone fracture healing in estrogen-competent mice suggesting that the osteoanabolic effects of vibration are rather mediated by ligand-independent ER alpha signaling.
引用
收藏
页数:11
相关论文
共 18 条
  • [1] Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing
    Billon-Gales, Audrey
    Krust, Andree
    Fontaine, Coralie
    Abot, Anne
    Flouriot, Gilles
    Toutain, Celine
    Berges, Hortense
    Gadeau, Alain-Pierre
    Lenfant, Francoise
    Gourdy, Pierre
    Chambon, Pierre
    Arnal, Jean-Francois
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (32) : 13311 - 13316
  • [2] The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice
    Borjesson, Anna E.
    Farman, Helen H.
    Engdahl, Cecilia
    Koskela, Antti
    Sjogren, Klara
    Kindblom, Jenny M.
    Stubelius, Alexandra
    Islander, Ulrika
    Carlsten, Hans
    Antal, Maria Cristina
    Krust, Andree
    Chambon, Pierre
    Tuukkanen, Juha
    Lagerquist, Marie K.
    Windahl, Sara H.
    Ohlsson, Claes
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (05) : 1117 - 1126
  • [3] Synergy between estrogen receptor α activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2
    Benecke, A
    Chambon, P
    Gronemeyer, H
    EMBO REPORTS, 2000, 1 (02) : 151 - 157
  • [4] Small molecule inhibitors targeting the activation function-2 site of estrogen receptor-α
    Singh, Kriti
    Munuganti, Ravi Shashi Nayana
    Leblanc, Eric
    Cherkasov, Artem
    Rennie, Paul S.
    CANCER RESEARCH, 2014, 74 (19)
  • [5] Activating function 2 (AF2) is the critical estrogen receptor a domain responsible for the growth inhibitory effects of 17β-estradiol in hormone independent breast cancer cells.
    Lim, SJ
    Ariazi, EE
    Pearce, ST
    Jordan, VC
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S177 - S177
  • [6] The Bone Sparing Effects of 2-Methoxyestradiol Are Mediated via Estrogen Receptor-α in Male Mice
    Eriksson, Anna L.
    Wilhelmson, Anna S.
    Fagman, Johan B.
    Ryberg, Henrik
    Koskela, Antti
    Tuukkanen, Juha
    Tivesten, Asa
    Ohlsson, Claes
    ENDOCRINOLOGY, 2016, 157 (11) : 4200 - 4205
  • [7] Estrogen receptor activation function 2 (AF-2) is essential for hormone-dependent transactivation and cell transformation induced by a v-Jun DNA binding domain-estrogen receptor chimera
    Dunn, CA
    Clark, W
    Black, EJ
    Gillespie, DAF
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2003, 1628 (03): : 147 - 155
  • [8] Characterization of novel small molecule inhibitors of estrogen receptor-activation function 2 (ER-AF2)
    Foo, Jane
    Gentile, Francesco
    Massah, Shabnam
    Morin, Helene
    Singh, Kriti
    Lee, Joseph
    Smith, Jason
    Ban, Fuqiang
    Leblanc, Eric
    Young, Robert
    Strynadka, Natalie
    Lallous, Nada
    Cherkasov, Artem
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [9] The Role of Activation Functions 1 and 2 of Estrogen Receptor-α for the Effects of Estradiol and Selective Estrogen Receptor Modulators in Male Mice (vol 28, pg 1117, 2013)
    Boerjesson, Anna E.
    Farman, Helen H.
    Engdahl, Cecilia
    Koskela, Antti
    Sjoegren, Klara
    Kindblom, Jenny M.
    Stubelius, Alexandra
    Islander, Ulrika
    Carlsten, Hans
    Antal, Maria Cristina
    Krust, Andree
    Chambon, Pierre
    Tuukkanen, Juha
    Lagerquist, Marie K.
    Windahl, Sara H.
    Ohlsson, Claes
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28 (11) : 2432 - 2432
  • [10] p33ING1b stimulates the transcriptional activity of the estrogen receptor at via its activation function (AF) 2 domain
    Toyama, T
    Iwase, H
    Yamashita, H
    Hara, Y
    Sugiura, H
    Zhang, ZH
    Fukai, I
    Miura, Y
    Riabowol, K
    Fujii, Y
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 87 (01): : 57 - 63